$84.20
0.58[0.69%]
Last update: 9:30AM Get Real Time Here
Haemonetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Haemonetics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | AM | HAE | Q4 | $0.77 | — | — | — | $304.42M | — | — | — | Get Alert |
02/08/2024 | AM | HAE | Q3 | $0.85 | $0.94 | $1.04 | 10.64% | $305.30M | $320.29M | $336.25M | 4.98% | Get Alert |
11/02/2023 | AM | HAE | Q2 | $0.83 | $0.89 | $0.99 | 11.24% | $297.49M | $313.12M | $318.18M | 1.62% | Get Alert |
08/08/2023 | AM | HAE | Q1 | $0.58 | $0.76 | $1.05 | 38.16% | $261.46M | $297.92M | $311.33M | 4.50% | Get Alert |
05/11/2023 | AM | HAE | Q4 | $0.65 | $0.70 | $0.77 | 10.00% | $265.00M | $289.64M | $304.42M | 5.10% | Get Alert |
02/07/2023 | AM | HAE | Q3 | $0.84 | $0.80 | $0.85 | 6.25% | $259.77M | $300.47M | $305.30M | 1.61% | Get Alert |
11/07/2022 | AM | HAE | Q2 | $0.60 | $0.67 | $0.83 | 23.88% | $239.90M | $269.22M | $297.49M | 10.50% | Get Alert |
08/10/2022 | AM | HAE | Q1 | $0.50 | $0.51 | $0.58 | 13.73% | $228.53M | $249.00M | $261.46M | 5.00% | Get Alert |
05/10/2022 | AM | HAE | Q4 | $0.46 | $0.60 | $0.65 | 8.33% | $225.03M | $257.82M | $265.00M | 2.79% | Get Alert |
02/08/2022 | AM | HAE | Q3 | $0.81 | $0.73 | $0.84 | 15.07% | $240.37M | $266.74M | $259.77M | -2.61% | Get Alert |
11/09/2021 | AM | HAE | Q2 | $0.62 | $0.61 | $0.60 | -1.64% | $209.49M | $241.40M | $239.90M | -0.62% | Get Alert |
08/11/2021 | AM | HAE | Q1 | $0.46 | $0.46 | $0.50 | 8.70% | $195.58M | $219.35M | $228.53M | 4.18% | Get Alert |
05/13/2021 | AM | HAE | Q4 | $0.69 | $0.67 | $0.46 | -31.34% | $238.49M | $222.98M | $225.03M | 0.92% | Get Alert |
02/02/2021 | AM | HAE | Q3 | $0.94 | $0.65 | $0.81 | 24.62% | $258.97M | $224.29M | $240.37M | 7.17% | Get Alert |
11/04/2020 | AM | HAE | Q2 | $0.87 | $0.51 | $0.62 | 21.57% | $252.57M | $207.65M | $209.49M | 0.88% | Get Alert |
08/04/2020 | AM | HAE | Q1 | $0.81 | $0.41 | $0.46 | 12.20% | $238.45M | $198.27M | $195.58M | -1.36% | Get Alert |
05/05/2020 | AM | HAE | Q4 | $0.61 | $0.73 | $0.69 | -5.48% | $249.29M | $247.15M | $238.49M | -3.50% | Get Alert |
02/04/2020 | AM | HAE | Q3 | $0.63 | $0.76 | $0.94 | 23.68% | $247.36M | $255.40M | $258.97M | 1.40% | Get Alert |
11/01/2019 | AM | HAE | Q2 | $0.56 | $0.69 | $0.87 | 26.09% | $241.58M | $249.77M | $252.57M | 1.12% | Get Alert |
Haemonetics (HAE) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on February 8, 2024 for Q3.
The Actual EPS was $1.04, which beat the estimate of $0.94.
The Actual Revenue was $336.3M, which beat the estimate of $320.3M.
Browse earnings estimates, EPS, and revenue on all stocks.